Primi, Marina Candido; Klein, Larry; Sant’Anna, Carlos Mauricio Rabello de; Franzblau, Scott Gary; Ferreira, Elizabeth Igne 
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS, TUBERCULOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIMI, Marina Candido et al. Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 01 maio 2026. , 2017APA
Primi, M. C., Klein, L., Sant’Anna, C. M. R. de, Franzblau, S. G., & Ferreira, E. I. (2017). Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Primi MC, Klein L, Sant’Anna CMR de, Franzblau SG, Ferreira EI. Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 26 res. FCF047.[citado 2026 maio 01 ]Vancouver
Primi MC, Klein L, Sant’Anna CMR de, Franzblau SG, Ferreira EI. Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 26 res. FCF047.[citado 2026 maio 01 ]
